Additionally, it examines the antitumor mechanisms of quinazolinone derivatives, such as microtubule polymerization, inhibition of cell cycle arrest, apoptosis induction, inhibition of tumor cell migration and invasion, suppression of angiogenesis, and targeting of epidermal growth factor receptor (EGFR) and PI3K pathways. The gene discussed is PIK3CB; the disease is neoplasm.